Search

everythinglearnresearchcommunity

for

Search:↓

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Both treatments improved hair quality and thickness equally, with mild side effects.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Flutamide effectively treats female pattern hair loss long-term with low doses being safe for the liver.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Baricitinib is a promising treatment for alopecia areata.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.